Literature DB >> 7531340

Differentiation of canine bone marrow cells with hemopoietic characteristics from an adherent stromal cell precursor.

R Huss1, D S Hong, P A McSweeney, C A Hoy, H J Deeg.   

Abstract

Stromal cell lines were established from canine long-term marrow cultures, cloned by limiting dilution, and maintained in stromal cell-conditioned medium. These cells grew adherent, maintained stable growth rate and morphology under standard conditions (in 20-30% conditioned medium; confluency, 70-90%), and supported hemopoiesis in long-term marrow cultures. In the presence of exogenous recombinant canine stem cell factor (rcSCF), round cells developed from the adherent layer, detached, and remained in culture as viable floating cells. Round floating cells also appeared when cultures were grown to > 90% confluency without rcSCF. Round cells were smaller than adherent cells, expressed CD34, showed basophilic plasma, and stained positive for c-kit, MHC-class II markers, and myeloid markers. In standard assays for colony formation, the detached cells produced granulocyte-macrophage colony-forming units (CFU-GM), fibroblast colony-forming units (CFU-F), and less well-defined colony-forming units. In addition, on allogeneic feeder cells in long-term cultures, these cells generated hemopoietic colonies. Strikingly, the differentiation was reversible: when nonadherent cells were resuspended at lower density in serum-containing medium, they reattached and grew to confluence when, once again, round cells detached. Detached cells from this secondary cycle produced mainly CFU-F and few CFU-GM when placed in clonal assays. These results suggest that some fibroblast-like stromal cells have the potential to differentiate into cells with hemopoietic characteristics. These observations provide evidence for the existence of a quiescent precursor of hemopoietic progenitors in the bone marrow stroma of the adult dog.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7531340      PMCID: PMC42697          DOI: 10.1073/pnas.92.3.748

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  THE PROBLEM OF THE STEM CELL: OBSERVATIONS IN DOGS FOLLOWING NITROGEN MUSTARD.

Authors:  E D THOMAS; T M FLIEDNER; D THOMAS; E P CRONKITE
Journal:  J Lab Clin Med       Date:  1965-05

2.  Cytological identification of radiation-chimaeras.

Authors:  C E FORD; J L HAMERTON; D W BARNES; J F LOUTIT
Journal:  Nature       Date:  1956-03-10       Impact factor: 49.962

3.  Long-term culture of canine bone marrow cells.

Authors:  F G Schuening; R Storb; J Meyer; S Goehle
Journal:  Exp Hematol       Date:  1989-06       Impact factor: 3.084

4.  Hemopoietic stromal microenvironment.

Authors:  M Tavassoli; A Friedenstein
Journal:  Am J Hematol       Date:  1983-09       Impact factor: 10.047

5.  Formation of haematopoietic microenvironment and haematopoietic stem cells from single human bone marrow stem cells.

Authors:  S Huang; L W Terstappen
Journal:  Nature       Date:  1994-04-14       Impact factor: 49.962

6.  The importance of cross-reactions between species: mouse allo-anti-Ia monoclonal antibodies as a powerful tool to define human Ia subsets.

Authors:  R S Accolla; D Birnbaum; M Pierres
Journal:  Hum Immunol       Date:  1983-09       Impact factor: 2.850

7.  Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny.

Authors:  H Castro-Malaspina; R E Gay; G Resnick; N Kapoor; P Meyers; D Chiarieri; S McKenzie; H E Broxmeyer; M A Moore
Journal:  Blood       Date:  1980-08       Impact factor: 22.113

8.  Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. II. Analysis of positive and negative regulators produced by stromal cells within the adherent layer.

Authors:  C J Eaves; J D Cashman; R J Kay; G J Dougherty; T Otsuka; L A Gaboury; D E Hogge; P M Lansdorp; A C Eaves; R K Humphries
Journal:  Blood       Date:  1991-07-01       Impact factor: 22.113

9.  Support of human hematopoiesis in long-term bone marrow cultures by murine stromal cells selectively expressing the membrane-bound and secreted forms of the human homolog of the steel gene product, stem cell factor.

Authors:  D Toksoz; K M Zsebo; K A Smith; S Hu; D Brankow; S V Suggs; F H Martin; D A Williams
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

10.  Long-term culture of B lymphocytes and their precursors from murine bone marrow.

Authors:  C A Whitlock; O N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

View more
  6 in total

Review 1.  Epithelial-mesenchymal transitions and the intersecting cell fate of fibroblasts and metastatic cancer cells.

Authors:  Eric G Neilson; David Plieth; Christo Venkov
Journal:  Trans Am Clin Climatol Assoc       Date:  2003

Review 2.  Peripheral blood stem cells: phenotypic diversity and potential clinical applications.

Authors:  Yichi Zhang; Bing Huang
Journal:  Stem Cell Rev Rep       Date:  2012-09       Impact factor: 5.739

3.  Evidence that fibroblasts derive from epithelium during tissue fibrosis.

Authors:  Masayuki Iwano; David Plieth; Theodore M Danoff; Chengsen Xue; Hirokazu Okada; Eric G Neilson
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

4.  LW/SO cell line: a tool for studying the phenotypical characterization and commitment of hematopoietic stem cells.

Authors:  S Oez; U Trautmann; M Smetak; J Birkmann; S al salemeh; E Gebhart; W M Gallmeier
Journal:  Ann Hematol       Date:  1996-05       Impact factor: 3.673

Review 5.  Epithelial-mesenchymal transition and its implications for fibrosis.

Authors:  Raghu Kalluri; Eric G Neilson
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

6.  CDK-inhibitor independent cell cycle progression in an experimental haematopoietic stem cell leukaemia despite unaltered Rb-phosphorylation.

Authors:  R Huss; S Theis; H J Deeg
Journal:  Br J Cancer       Date:  1999-11       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.